The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Phase I/Randomized Phase II Study of MLN0128 v.s Pazopanib in Patients with Locally Advanced/Unresectable and/or Metastatic Sarcoma:Alliance A091304.
 
William D. Tap
Consulting or Advisory Role - Advaxis; Ariad; Daiichi Sankyo; EMD Serono; Janssen; Lilly; Plexxikon
Travel, Accommodations, Expenses - Boehringer Ingelheim
Other Relationship - Morphotek
 
Michelle R. Mahoney
No Relationships to Disclose
 
Anthony John Jaslowski
No Relationships to Disclose
 
Laura E. Horvath
No Relationships to Disclose
 
Gary K. Schwartz
Honoraria - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis